These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). Fujimoto K, Oka T, Morimoto M. Cancer Res; 1987 Mar 15; 47(6):1516-22. PubMed ID: 2434218 [Abstract] [Full Text] [Related]
3. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity. McRipley RJ, Burns-Horwitz PE, Czerniak PM, Diamond RJ, Diamond MA, Miller JL, Page RJ, Dexter DL, Chen SF, Sun JH. Cancer Res; 1994 Jan 01; 54(1):159-64. PubMed ID: 8261436 [Abstract] [Full Text] [Related]
4. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N, Nagasu T, Fujita F, Watanabe T, Tsukahara K, Funahashi Y, Fujita M, Taguchi T, Yoshino H, Kitoh K. Cancer Res; 1994 Apr 01; 54(7):1702-6. PubMed ID: 8137285 [Abstract] [Full Text] [Related]
5. Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors. Plowman J, Harrison SD, Dykes DJ, Paull KD, Narayanan VL, Tobol HK, Martin J, Griswold DP. Cancer Res; 1989 Apr 15; 49(8):1909-15. PubMed ID: 2702634 [Abstract] [Full Text] [Related]
6. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M. Cancer Res; 1982 Feb 15; 42(2):440-4. PubMed ID: 7055799 [Abstract] [Full Text] [Related]
7. Preclinical antitumor activity of bizelesin in mice. Carter CA, Waud WR, Li LH, DeKoning TF, McGovren JP, Plowman J. Clin Cancer Res; 1996 Jul 15; 2(7):1143-9. PubMed ID: 9816280 [Abstract] [Full Text] [Related]
8. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma. Lippman MM, Laster WR, Abbott BJ, Venditti J, Baratta M. Cancer Res; 1975 Apr 15; 35(4):939-45. PubMed ID: 1116151 [Abstract] [Full Text] [Related]
9. Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice. Wallace RE, Murdock KC, Angier RB, Durr FE. Cancer Res; 1979 May 15; 39(5):1570-4. PubMed ID: 427798 [Abstract] [Full Text] [Related]
17. [Antitumor effect of a benzoylphenylurea derivative HO-221]. Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Tsukagoshi S, Taguchi T. Gan To Kagaku Ryoho; 1990 Dec 15; 17(12):2353-9. PubMed ID: 2260871 [Abstract] [Full Text] [Related]
18. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C. Morimoto M, Ashizawa T, Ohno H, Azuma M, Kobayashi E, Okabe M, Gomi K, Kono M, Saitoh Y, Kanda Y. Cancer Res; 1991 Jan 01; 51(1):110-5. PubMed ID: 1988076 [Abstract] [Full Text] [Related]